Prophylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Prophylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemia

Published:2016-05-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lauw Mandy N¹²,Hubers Lowiek M²,van Ommen Cornelia H³,Hutten Barbara A⁴,Biemond Bart J¹,Middeldorp Saskia²

Affiliation:

1. Academic Medical Center; Department of Hematology; Meibergdreef 9, F4-224 Amsterdam Netherlands 1105 AZ

2. Academic Medical Center; Department of Vascular Medicine; Meibergdreef 9, F4-159.2 Amsterdam Netherlands 1105 AZ

3. Emma Children's Hospital / Academic Medical Center; Department of Paediatric Haematology; PO Box 22660 Amsterdam Netherlands 1100 DD

4. Academic Medical Center; Department of Clinical Epidemiology & Biostatistics; Meibergdreef 9 Amsterdam Netherlands 1105 AZ

Publisher

Wiley

Subject

Pharmacology (medical)

Reference42 articles.

1. Anticoagulation for patients with cancer and central venous catheters;Akl;Cochrane Database of Systematic Reviews,2011

2. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases;Appel;Blood Coagulation & Fibrinolysis,2006

3. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia;Appel;Thrombosis and Haemostasis,2008

4. Personal practice: how we manage the risk of bleeding and thrombosis in children and young adults with acute lymphoblastic leukaemia;Astwood;British Journal of Haematology,2011

5. Thrombosis in children with acute lymphoblastic leukemia. Part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia;Athale;Thrombosis Research,2003